INFACARE PHARMACEUTICAL CORP — Form D

INFACARE PHARMACEUTICAL CORP of TREVOSE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2014-12-09. The offering totals $1.3M, of which $1.3M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2014-12-09
Form: D
Accession: 0001174264-14-000002
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $1.3M
Amount sold: $1.3M
Investors: 2
Date of first sale: 2014-12-08
Security types: equity, debt
Revenue range: Decline to Disclose
SEC file number: 021-229740

Issuer

Name: INFACARE PHARMACEUTICAL CORP
CIK: 0001174264
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 8 NESHAMINY INTERPLEX, SUITE 221, TREVOSE, PA, 19053
Phone: 267-515-5850

Officers, directors & promoters (10)

Name	Role	Location
Richard Vietor	Director	Trevose, PA
Patrick Enright	Director	Menlo Park, CA
Peter Barrett	Director	Palo Alto, CA
Dan Burns	Director	Phoenix, AZ
Dan Burns	Executive Officer	Phoenix, AZ
William Crouse	Director	Malvern, PA
Robert Vukovich	Director	Trevose, PA
Harold Werner	Director	Trevose, PA
E. Ronald Goldfuss	Executive Officer	Trevose, PA
Ron Goldfuss	Executive Officer	Trevose, PA

Other filings by this issuer (5)

Filed	Form	Offering	Sold
2017-06-07	D	$11.0M	$3.5M
2016-11-04	D	$11.0M	$5.5M
2015-07-08	D	$12.1M	$12.1M
2014-10-21	D	$750K	$750K
2013-03-20	D	$21.6M	$3.6M

More